Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • Artificial Intelligence (12)
  • Asthma (185)
  • Basic immunology (58)
  • Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • Drug allergy (172)
  • ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • Epithelial cell biology (8)
  • Food allergy (195)
  • x Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • x Prevention (40)
  • Systems medicine (13)
Poster available until
  • Until platform closure (2)
Poster categories
  • e-Thematic Poster Session (3)
  • Thematic Poster Session (52)
keywords
Session Reference
  • L-TPS02 (1)
  • L-TPS03 (3)
  • L-TPS08 (1)
  • L-TPS10 (2)
  • L-TPS13 (1)
  • L-TPS14 (2)
  • L-TPS16 (1)
  • L-TPS20 (1)
  • L-TPS21 (1)
  • TPS03 (1)
  • TPS05 (1)
  • TPS10 (3)
  • TPS14 (1)
  • TPS15 (1)
  • TPS16 (2)
  • TPS19 (3)
  • TPS20 (1)
  • TPS23 (3)
  • TPS25 (1)
  • TPS28 (3)
  • TPS30 (1)
  • TPS31 (1)
  • TPS34 (2)
  • TPS37 (1)
  • TPS41 (1)
  • TPS44 (2)
  • TPS45 (1)
  • TPS47 (1)
  • TPS51 (1)
  • TPS57 (2)
  • TPS68 (2)
  • TPS69 (2)
  • TPS75 (4)
57 results
Thumbnail

D3.439 - On-demand treatment of hereditary angioedema attacks: Assessing self-treatment, outcomes and barriers to early intervention

Thumbnail

D1.171 - Preventive Effects of Lactococcus lactis on Ovalbumin-Induced Food Allergy in Mice

Thumbnail

D1.175 - Impact of dog ownership on allergen exposure and tolerance development: Analysis of Can f 1 levels in house dust samples

Thumbnail

D1.285 - Analysis of systemic food reactions in patients sensitized to Bet v1 in Madrid (Spain)

Thumbnail

D1.315 - Classifying the unclassifiable: diagnosis, characterization, and management of adults with unclassified primary antibody deficiency (unPAD)

Thumbnail

D1.72 - Comparison of the allergenic composition of available SPTs for the diagnosis of sensitization to D. pteronyssinus

Thumbnail

D2.142 - Smoking cessation advice to parents in children with bronchial asthma- still it is a long way to go

Thumbnail

D2.291 - The level of knowledge of adolescent and young adults about food allergies and anaphylaxis: Key information that can save lives - a pilot study

Thumbnail

D2.387 - Reducing the Carbon Footprint of Cetirizine Prescription: Exploring Patient Perspectives on Formulation Choice in an Allergy Clinic

Thumbnail

D2.396 - Evaluating Advanced Fabric Care Technologies for Effective Dust Mite Eradication to Mitigate the Risk of Asthma

Thumbnail

D2.422 - Supporting second victims: linkages between patient safety and well-being of healthcare workers in allergy departments

Thumbnail

D1.390 - Long-term safety and efficacy of navenibart in participants with hereditary angioedema (HAE): Initial combined results from ALPHA-STAR and ALPHA-SOLAR

Thumbnail

D1.397 - Eosinophilic Pneumonia Triggered by Toxocara canis in a Patient with Kartagener Syndrome: A Case Report Highlighting Diagnostic Challenges and Interdisciplinary Management

Thumbnail

D1.398 - Retrospective study of the effect of bacterial immunotheraphy on patients with chronic respiratory diseases

Thumbnail

D1.404 - Use of inactivated polybacterial mucosal vaccine (IPMV) as part of the treatment for the reduction of recurrent acute respiratory infections

Thumbnail

D1.414 - Parents’ hesitancy towards vaccination: a Cross-sectional study in Saudi Arabia

Thumbnail

D1.43 - Performance Evaluation of a Semi-Quantitative Rapid Test Kit for Dust Mites: For Home Self-Monitoring and Control Effectiveness Assessment

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Page 2
  • Current page 3
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM